{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:14:02Z","timestamp":1791288842100,"version":"4.3.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Currently, the only reliable indicator of malignancy in pheochromocytoma is the presence of distant metastasis or extensive local invasion; predicting behavior of pheochromocytoma remains challenging. We aimed to correlate the behavior of pheochromocytoma with its expression of nm-23, cyclooxygenase (COX)-2, and galectin-3 (genes used to predict the course of some neoplastic diseases), evaluated immunohistochemically in 55 paraffin blocks of formalin-fixed pheochromocytoma specimens with confirmed behavior.<\/jats:p>\n               <jats:p>In 3 (7%) of 44 benign and 7 (64%) of 11 malignant pheochromocytomas, there was negative nm-23 expression (P = .000). COX-2 immunoreactivity was positive in 10 (23%) of benign and 9 (82%) of malignant tumors (P = .000). Galectin-3 was expressed in 5 (11%) of benign and 9 (82%) of malignant pheochromocytomas (P = .000).<\/jats:p>\n               <jats:p>Negative nm-23, along with positive COX-2 or galectin-3, predicted malignancy with 100% specificity. Dual negativity for galectin-3 and COX-2, along with nm-23 positivity, indicated benign behavior with 100% sensitivity.<\/jats:p>\n               <jats:p>In early pheochromocytoma, evaluation of nm-23, galectin-3, and COX-2 expression could predict the outcome. Larger studies seem necessary to confirm the potential practical value of our findings.<\/jats:p>","DOI":"10.1309\/ajcpi8ajluz3czln","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T18:37:47Z","timestamp":1298572667000},"page":"454-460","source":"Crossref","is-referenced-by-count":20,"title":["Expression of Galectin-3, nm-23, and Cyclooxygenase-2 Could Potentially Discriminate Between Benign and Malignant Pheochromocytoma"],"prefix":"10.1093","volume":"135","author":[{"given":"Hiva","family":"Saffar","sequence":"first","affiliation":[{"name":"1Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Sanii","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Heshmat","sequence":"additional","affiliation":[{"name":"2Endocrinology & Metabolism Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Haghpanah","sequence":"additional","affiliation":[{"name":"2Endocrinology & Metabolism Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[{"name":"2Endocrinology & Metabolism Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Rajabiani","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Azimi","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Tavangar","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"key":"2023011909492899700_b1-1350454","first-page":"2191","article-title":"The adrenal gland","volume-title":"Silverberg\u2019s Principles and Practice of Surgical Pathology and Cytopathology","author":"Wieneke","year":"2006","edition":"4th ed"},{"key":"2023011909492899700_b2-1350454","first-page":"1109","article-title":"Tumors of the adrenal gland","volume-title":"Diagnostic Histopathology of Tumors","author":"Lack","year":"2007","edition":"3rd ed"},{"key":"2023011909492899700_b3-1350454","first-page":"576","article-title":"The adrenal glands","volume-title":"Sternberg\u2019s Diagnostic Surgical Pathology","author":"DeLellis","year":"2010","edition":"5th ed"},{"key":"2023011909492899700_b4-1350454","first-page":"1136","article-title":"Adrenal gland and other paraganglia","volume-title":"Rosai and Ackerman\u2019s Surgical Pathology","author":"Rosai","year":"2004","edition":"9th ed"},{"key":"2023011909492899700_b5-1350454","first-page":"1765","article-title":"Adrenal gland","volume-title":"Modern Surgical Pathology","author":"Weiss","year":"2003"},{"key":"2023011909492899700_b6-1350454","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.prp.2010;01:007","article-title":"Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma","volume":"206","author":"Tavangar","year":"2010","journal-title":"Pathol Res Pract"},{"key":"2023011909492899700_b7-1350454","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ijc.20670","article-title":"Down-regulation of metastasis suppressor genes in malignant pheochromocytoma","volume":"114","author":"Ohta","year":"2005","journal-title":"Int J Cancer"},{"key":"2023011909492899700_b8-1350454","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1097-0215(19971009)73:2<297::AID-IJC22>3.0.CO;2-B","article-title":"Down-regulation of the nm23.h1 gene inhibits cell proliferation","volume":"73","author":"Cipollini","year":"1997","journal-title":"Int J Cancer"},{"key":"2023011909492899700_b9-1350454","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/jnci\/86.24.1838","article-title":"A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest","volume":"86","author":"Howlett","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"2023011909492899700_b10-1350454","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/dna.1998.17.335","article-title":"Expression of metastasis-associated genes h-mts1 (S100A4) and nm23 in carcinoma of breast is related to disease progression","volume":"17","author":"Albertazzi","year":"1998","journal-title":"DNA Cell Biol"},{"key":"2023011909492899700_b11-1350454","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ijc.11676","article-title":"Expression profile of genes associated with antimetastatic gene: nm23-mediated metastasis inhibition in breast carcinoma cells","volume":"109","author":"Zhao","year":"2004","journal-title":"Int J Cancer"},{"key":"2023011909492899700_b12-1350454","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3748\/wjg.v11.i9.1378","article-title":"Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma.","volume":"11","author":"Liu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"2023011909492899700_b13-1350454","first-page":"1553","article-title":"The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma [in Chinese]","volume":"82","author":"Liu","year":"2002","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2023011909492899700_b14-1350454","first-page":"334","article-title":"nm23-H1 gene inhibits lung cancer cell invasion through down-regulation of PKC signal pathway [in Chinese]","volume":"28","author":"Nie","year":"2006","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"2023011909492899700_b15-1350454","first-page":"278","article-title":"Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1 [in Chinese]","volume":"24","author":"Che","year":"2005","journal-title":"Ai Zheng"},{"key":"2023011909492899700_b16-1350454","first-page":"81","article-title":"Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non\u2013small cell lung cancer","volume":"18","author":"Hsu","year":"2007","journal-title":"Oncol Rep"},{"key":"2023011909492899700_b17-1350454","first-page":"650","article-title":"Association between nm23-H1 gene expression and metastasis of ovarian carcinoma","volume":"23","author":"Gao","year":"2004","journal-title":"Ai Zheng"},{"key":"2023011909492899700_b18-1350454","first-page":"1825","article-title":"Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression","volume":"54","author":"Mandai","year":"1994","journal-title":"Cancer Res"},{"key":"2023011909492899700_b19-1350454","first-page":"3595","article-title":"The role of nm23-H1 in the progression of transitional cell bladder cancer","volume":"6","author":"Chow","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2023011909492899700_b20-1350454","first-page":"788","article-title":"The effects of nm23-H1 gene cell transfection on abilities of invasion, adhesion and chemotherapeutic sensitivity of bladder cancer T-24 cell line [in Chinese]","volume":"38","author":"Cui","year":"2007","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"2023011909492899700_b21-1350454","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.urology.2004.12.032","article-title":"Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2","volume":"65","author":"Ohba","year":"2005","journal-title":"Urology"},{"issue":"suppl 2","key":"2023011909492899700_b22-1350454","first-page":"S61","article-title":"Cyclooxygenase 2 and carcinogenesis [in French]","volume":"91","author":"Rodrigues","year":"2004","journal-title":"Bull Cancer"},{"key":"2023011909492899700_b23-1350454","first-page":"565","article-title":"Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer","volume":"129","author":"Zhang","year":"2005","journal-title":"Gastroenterology"},{"key":"2023011909492899700_b24-1350454","first-page":"1393","article-title":"COX-2 overexpression increases motility and invasion of breast cancer cells","volume":"26","author":"Singh","year":"2005","journal-title":"Int J Oncol"},{"key":"2023011909492899700_b25-1350454","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2407-6-181","article-title":"Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression","volume":"6","author":"Larkins","year":"2006","journal-title":"BMC Cancer"},{"key":"2023011909492899700_b26-1350454","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10552-007-9003-y","article-title":"NSAIDs and breast cancer recurrence in a prospective cohort study","volume":"18","author":"Kwan","year":"2007","journal-title":"Cancer Causes Control"},{"key":"2023011909492899700_b27-1350454","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jss.2005.11.582","article-title":"COX-2 induces IL-11 production in human breast cancer cells","volume":"131","author":"Singh","year":"2006","journal-title":"J Surg Res"},{"key":"2023011909492899700_b28-1350454","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/modpathol.3800285","article-title":"Role of COX-2, thromboxane A2 synthase, and prostaglandin I2 synthase in papillary thyroid carcinoma growth","volume":"18","author":"Kajita","year":"2005","journal-title":"Mod Pathol"},{"key":"2023011909492899700_b29-1350454","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/hed.20542","article-title":"Cyclooxygenase-2 expression in medullary thyroid carcinoma","volume":"29","author":"Popovtzer","year":"2007","journal-title":"Head Neck"},{"key":"2023011909492899700_b30-1350454","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1385\/EP:13:4:331","article-title":"An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for COX-1 and COX-2 enzymes","volume":"13","author":"Bell","year":"2002","journal-title":"Endocr Pathol"},{"key":"2023011909492899700_b31-1350454","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/carcin\/bgh100","article-title":"COX-2 gene promoter haplotypes and prostate cancer risk","volume":"25","author":"Panguluri","year":"2004","journal-title":"Carcinogenesis"},{"issue":"12 pt 2","key":"2023011909492899700_b32-1350454","doi-asserted-by":"crossref","first-page":"4266s","DOI":"10.1158\/1078-0432.CCR-040014","article-title":"Cyclooxygenase as a target in lung cancer","volume":"10","author":"Brown","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2023011909492899700_b33-1350454","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1210\/jcem.86.11.8052","article-title":"Increased expression of cyclooxygenase-2 in malignant pheochromocytomas","volume":"86","author":"Salmenkivi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2023011909492899700_b34-1350454","first-page":"111","article-title":"Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma","volume":"54","author":"Jakubiak-Wielganowicz","year":"2003","journal-title":"Pol J Pathol"},{"key":"2023011909492899700_b35-1350454","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.canlet.2004.03.006","article-title":"Galectin-3 expression in non\u2013small cell lung carcinoma","volume":"212","author":"Puglisi","year":"2004","journal-title":"Cancer Lett"},{"key":"2023011909492899700_b36-1350454","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ejcts.2007.01.072","article-title":"The role of microvascularization and growth\/adhesion-regulatory lectins in the prognosis of non\u2013small cell lung cancer in stage II","volume":"31","author":"Sz\u00f6ke","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"2023011909492899700_b37-1350454","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0046-8177(96)90313-5","article-title":"Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma","volume":"27","author":"van den Brule","year":"1996","journal-title":"Hum Pathol"},{"key":"2023011909492899700_b38-1350454","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.yexcr.2006.11.005","article-title":"Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: implications in the extracellular functions of the lectin","volume":"313","author":"Baptiste","year":"2007","journal-title":"Exp Cell Res"},{"key":"2023011909492899700_b39-1350454","first-page":"3117","article-title":"Galectin-3 expression is a potent prognostic marker in colorectal cancer","volume":"25","author":"Endo","year":"2005","journal-title":"Anticancer Res"},{"key":"2023011909492899700_b40-1350454","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1196\/annals.1353.028","article-title":"Distinct expression of galectin-3 in pheochromocytomas","volume":"1073","author":"Gimm","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2023011909492899700_b41-1350454","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/135\/3\/454\/48769817\/ajcp_135_3_454.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/135\/3\/454\/48769817\/ajcp_135_3_454.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T11:32:43Z","timestamp":1674127963000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/135\/3\/454\/1766655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,1]]},"published-print":{"date-parts":[[2011,3,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpi8ajluz3czln","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,3,1]]},"published":{"date-parts":[[2011,3,1]]}}}